Search results for "COPD"
LABAs, LAMAs for COPD may be associated with increased CVD risk in first 30 days of use
Study authors caution physicians to closely monitor new users of long-acting beta2-agonists (LABAs) or long-acting antimuscarinic antagonists (LAMAs) for cardiovascular symptoms.
https://immattersacp.org/weekly/archives/2018/01/09/4.htm
9 Jan 2018
Catch up on new COPD guidelines
Updated guidelines for chronic obstructive pulmonary disease revised the definition and staging of the condition, and an expert offers tips for optimal care.
https://immattersacp.org/archives/2018/06/catch-up-on-new-copd-guidelines.htm
1 Jun 2018
MKSAP Quiz: Follow-up for severe COPD
A 55-year-old man is evaluated in follow-up for severe COPD, which was diagnosed 2 years ago. He has had two exacerbations in the past year requiring hospitalization, and his baseline exercise tolerance is low. Following a physical exam and other tests, what is most likely to benefit this patient?
https://immattersacp.org/weekly/archives/2018/08/14/3.htm
14 Aug 2018
EpiPen expiration date extended, first generic approved
This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2018/10/epipen-expiration-date-extended-first-generic-approved.htm
1 Oct 2018
Triple inhaler therapy associated with reduced COPD exacerbations, higher rates of pneumonia
Results of the systematic review and meta-analysis suggest that triple inhaler therapy should be limited to patients with more severe symptoms of chronic obstructive pulmonary disease (COPD) that cannot be adequately managed by dual therapy, the authors said.
https://immattersacp.org/weekly/archives/2018/11/13/2.htm
13 Nov 2018
A defense of proton-pump inhibitors
Data on their risks may seem persuasive, but one expert is not convinced.
https://immattersacp.org/archives/2019/01/a-defense-of-proton-pump-inhibitors.htm
1 Jan 2019
Evidence evolving on aspirin as prevention
Practice-changing points may influence how internists prescribe aspirin for the primary prevention of heart disease.
https://immattersacp.org/archives/2019/03/evidence-evolving-on-aspirin-as-prevention.htm
1 Mar 2019
MKSAP Quiz: 3-year history of dyspnea, cough
A 69-year-old man is evaluated for a three-year history of dyspnea and chronic productive cough. He was diagnosed with chronic obstructive pulmonary disease (COPD) two years ago and has been treated for three exacerbations in the past year. He is taking tiotropium, fluticasone/salmeterol, and albuterol inhalers. Which long-term treatment is most likely to reduce exacerbations?
https://immattersacp.org/weekly/archives/2019/03/05/3.htm
5 Mar 2019
Palliative care's place outside cancer
Integrated palliative care is important in offering comfort measures to patients with conditions that are expected to shorten their life spans.
https://immattersacp.org/archives/2019/06/palliative-cares-place-outside-cancer.htm
1 Jun 2019
MKSAP Quiz: Follow-up of progressive dyspnea
A 42-year-old man is evaluated in the office for follow-up of progressive dyspnea of 2 years' duration. He first noted dyspnea with exercise but now has symptoms when walking up a flight of stairs. Pulmonary function tests 2 years ago showed moderate airflow obstruction. He has no significant smoking history but a family history of emphysema. After physical examination and a chest radiograph, what is the most appropriate test to perform next?
https://immattersacp.org/weekly/archives/2019/06/04/3.htm
4 Jun 2019